Healthcare -
Biotechnology - NASDAQ - US
$ 7.37
3.08 %
$ 365 M
Market Cap
-1.47
P/E
RGNX - LONG-TERM INVESTMENTS
Long-term Investments RGNX - REGENXBIO Inc.
38.9 M
LAST VALUE
-68.51%
2 YEAR CAGR
-23.75%
5 YEAR CAGR
62.49%
10 YEAR CAGR